Skip to main content
Clinical Trials/NCT01748006
NCT01748006
Unknown
Not Applicable

The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure

Finn Gustafsson1 site in 1 country30 target enrollmentJune 2012
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Finn Gustafsson
Enrollment
30
Locations
1
Primary Endpoint
The correlation between levels of plasma copeptin and vasopressin with left ventricular filling pressure and cardiac output
Last Updated
10 years ago

Overview

Brief Summary

The relationship between the activation of the vasopressin system and central hemodynamics in heart failure (including right and left heart filling pressures and cardiac output) is not clear. The investigators intend to examine the correlation between levels of copeptin and vasopressin and the central hemodynamic system in patients with advanced (class III or IV) heart failure. The investigators also aim to examine the relationship of selected cardiac biomarkers in blood and urine with cardiac filling pressures and cardiac output in patients with decompensated heart failure.

The study population will consist of 30 patients admitted to the Department of Cardiology at Copenhagen University Hospital. Only patients for whom the attending cardiologist has already decided upon right heart catheterization for clinical/treatment reasons will be recruited for the study.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
June 2016
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Finn Gustafsson
Responsible Party
Sponsor Investigator
Principal Investigator

Finn Gustafsson

MD, DMSc

Rigshospitalet, Denmark

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Left ventricular ejection fraction \< 40 %
  • Diagnosed symptomatic heart failure treated with heart failure medications for at least 30 days.
  • Clinical indication for right heart catheterization for clinical/treatment reasons
  • NYHA-class III-IV
  • Relevant heart failure treatment as tolerated by the patient

Exclusion Criteria

  • Absence of clinical/treatment indication of right heart catheterization
  • Syndrome of Inappropriate Secretion of ADH (SIADH)
  • Recent acute myocardial infarction within the last 30 days
  • Presence of infection or inflammatory disease
  • Malignant disease
  • Subjects unwilling or unable to provide written consent

Outcomes

Primary Outcomes

The correlation between levels of plasma copeptin and vasopressin with left ventricular filling pressure and cardiac output

Time Frame: Day 1

Secondary Outcomes

  • The correlation between levels of plasma copeptin and vasopressin with urine aquaporin-2 concentration(Day 1)
  • The correlation between biomarkers levels and survival free of transplantation- and left ventricular assist device insertion(1 year)
  • The correlation between New York Heart Association (NYHA) class and levels of plasma copeptin and vasopressin(Day 1)

Study Sites (1)

Loading locations...

Similar Trials